PLoS One. 2021 Nov 30;16(11):e0260597. doi: 10.1371/journal.pone.0260597. eCollection 2021.
The use of heuristics in genetic testing decision-making: A qualitative interview study.
PloS one
Bettina Maria Zimmermann, David Martin Shaw, Bernice Elger, Insa Koné
Affiliations
Affiliations
- Institute for Biomedical Ethics, University of Basel, Basel, Switzerland.
- Institute of History and Ethics in Medicine, School of Medicine, Technical University of Munich, Munich, Germany.
- Care and Public Health Research Institute, Maastricht University, Maastricht, The Netherlands.
- Center for Legal Medicine, University of Geneva, Geneva, Switzerland.
PMID: 34847204
PMCID: PMC8631642 DOI: 10.1371/journal.pone.0260597
Abstract
BACKGROUND: Decision-making concerning predictive genetic testing for hereditary cancer syndromes is inherently complex. This study aims to investigate what kind of complexities adults undergoing genetic counseling in Switzerland experience, how they deal with them, and what heuristics they use during the decision-making process.
METHODS: Semi-structured qualitative interviews with eighteen Swiss adults seeking genetic counseling for hereditary cancer syndrome genetic testing and two counseling physicians were conducted and analyzed using a grounded theory approach.
RESULTS: Counselees stated that once they were aware of their eligibility for genetic testing they perceived an inevitable necessity to make a decision in a context of uncertainties. Some counselees perceived this decision as simple, others as very complex. High emotional involvement increased perceived complexity. We observed six heuristics that counselees used to facilitate their decision: Anticipating the test result; Focusing on consequences; Dealing with information; Interpreting disease risk; Using external guidance; and (Re-)Considering the general uncertainty of life.
LIMITATIONS: Our findings are limited to the context of predictive genetic testing for hereditary cancer syndromes. This qualitative study does not allow extrapolation of the relative frequency of which heuristics occur.
CONCLUSIONS: The use of heuristics is an inherent part of decision-making, particularly in the complex context of genetic testing for inherited cancer predisposition. However, some heuristics increase the risk of misinterpretation or exaggerated external influences. This may negatively impact informed decision-making. Thus, this study illustrates the importance of genetic counselors and medical professionals being aware of these heuristics and the individual manner in which they might be applied in the context of genetic testing decision-making. Findings may offer practical support to achieve this, as they inductively focus on the counselees' perspective.
Conflict of interest statement
The authors have declared that no competing interests exist.
References
- Nurse Res. 2006 Jul 1;13(4):84 - PubMed
- Am J Med Genet C Semin Med Genet. 2018 Mar;178(1):98-107 - PubMed
- Qual Health Res. 2006 Jan;16(1):97-118 - PubMed
- J Health Psychol. 2002 Jul;7(4):469-84 - PubMed
- Med Health Care Philos. 2007 Dec;10(4):417-31 - PubMed
- J Natl Compr Canc Netw. 2019 Sep 1;17(9):1032-1041 - PubMed
- Mol Aspects Med. 2019 Oct;69:10-26 - PubMed
- Med Humanit Rev. 1987 Jan;1(1):78-82 - PubMed
- Health Commun. 2011 Oct;26(7):667-75 - PubMed
- Health Psychol. 2005 Jul;24(4S):S35-40 - PubMed
- Ann Behav Med. 2006 Feb;31(1):45-52 - PubMed
- Clin Ter. 2011;162(5):e141-4 - PubMed
- Med Decis Making. 2015 May;35(4):539-57 - PubMed
- Patient Educ Couns. 2018 Mar;101(3):422-427 - PubMed
- J Med Ethics. 2004 Oct;30(5):435-9; discussion 439-40 - PubMed
- Psychooncology. 2005 Jan;14(1):34-48 - PubMed
- Sociol Health Illn. 2003 Nov;25(7):838-65 - PubMed
- JAMA Oncol. 2015 Oct;1(7):943-51 - PubMed
- Health Expect. 2008 Sep;11(3):220-31 - PubMed
- Soc Sci Med. 2016 Aug;163:21-7 - PubMed
- Health Care Anal. 2007 Mar;15(1):13-23 - PubMed
- Psychooncology. 2012 Jun;21(6):611-7 - PubMed
- Cancer Nurs. 2017 Sep/Oct;40(5):386-393 - PubMed
- Eur J Hum Genet. 2013 Mar;21(3):256-60 - PubMed
- Nat Rev Cancer. 2016 Sep;16(9):599-612 - PubMed
- J Genet Couns. 2007 Aug;16(4):419-32 - PubMed
- Annu Rev Psychol. 2011;62:451-82 - PubMed
- Ann Behav Med. 2015 Aug;49(4):616-21 - PubMed
- J Genet Couns. 2017 Apr;26(2):232-243 - PubMed
- Community Genet. 2003;6(4):224-34 - PubMed
- Eur J Hum Genet. 2020 Aug;28(8):1010-1019 - PubMed
- Am J Pathol. 2013 Oct;183(4):1038-1051 - PubMed
- J Genet Couns. 2017 Oct;26(5):999-1007 - PubMed
- Int J Qual Health Care. 2007 Dec;19(6):349-57 - PubMed
- Tumori. 2015 Jul 24;101(4):e113-4 - PubMed
- J Pers Soc Psychol. 2001 Dec;81(6):973-88 - PubMed
- Qual Health Res. 2011 Apr;21(4):502-19 - PubMed
- J Genet Couns. 2009 Jun;18(3):252-64 - PubMed
- Behav Med. 2005 Fall;31(3):93-105 - PubMed
- Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):728-35 - PubMed
- Med Decis Making. 2011 Nov-Dec;31(6):828-38 - PubMed
- Bioethics. 2021 Feb;35(2):199-206 - PubMed
- Genet Med. 2014 Jul;16(7):516-21 - PubMed
- Patient Educ Couns. 1998 Sep;35(1):53-62 - PubMed
- Oncotarget. 2017 Jan 10;8(2):1957-1971 - PubMed
- Health Psychol. 2013 Nov;32(11):1158-69 - PubMed
- Patient Educ Couns. 2018 Dec;101(12):2083-2089 - PubMed
- J Health Psychol. 2002 Mar;7(2):131-44 - PubMed
- BMJ. 2001 Apr 28;322(7293):1052-6 - PubMed
- Genet Med. 2014 Jul;16(7):522-8 - PubMed
Publication Types